In vivo and in vitro studies of Danzhi Jiangtang capsules against diabetic cardiomyopathy via TLR4/MyD88/NF-κB signaling pathway

• Main Authors: Hui Shi (Author), Peng Zhou (Author), Ying-qun Ni (Author), Shu-shu Wang (Author), Rui Song (Author), An-lu Shen (Author), Zhao-hui Fang (Author), Liang Wang (Author)
• 格式: 圖書
• 出版: Elsevier, 2021-12-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Objectives: Danzhi Jiangtang capsule (DJC) is widely used for preventing and treating diabetic cardiomyopathy (DCM). However, the underlying mechanisms of the anti-inflammatory and antiapoptotic activities are unclear. Methods: In the in vivo diabetic cardiomyopathy rat model, cardiac function was m...